Evidence map›Paper›PMID 34075211›Full record

ArticleEuropean journal of human genetics : EJHG2021

A MT-TL1 variant identified by whole exome sequencing in an individual with intellectual disability, epilepsy, and spastic tetraparesis.

Elke de Boer, Charlotte W Ockeloen, Leslie Matalonga, Rita Horvath, Solve-RD SNV-indel working group, Richard J Rodenburg, Marieke J H Coenen, Mirian Janssen, Dylan Henssen, Christian Gilissen and 7 more

Erratum issuedOpen access · hybridAbstract readCase Reports
In one paragraph

Article in European journal of human genetics : EJHG, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Solving the unsolved rare diseases in Europe.European journal of human genetics : EJHG · 2021
    Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 18 institutions in 10 countries.

Elke de BoerDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Charlotte W OckeloenDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. charlotte.ockeloen@radboudumc.nl.ORCID 0000-0003-0329-1520
Leslie MatalongaCNAG-CRG, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Rita HorvathDepartment of Clinical Neurosciences, University of Cambridge, John Van Geest Cambridge Centre for Brain Repair, Cambridge, UK.ORCID 0000-0002-9841-170X
Solve-RD SNV-indel working group
Richard J RodenburgDepartment of Laboratory Medicine, Translational Metabolic Laboratory, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0001-5227-3527
Marieke J H CoenenDepartment of Human Genetics, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Mirian JanssenDepartment of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Dylan HenssenDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
Christian GilissenDepartment of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0003-1693-9699
Wouter SteyaertDepartment of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0001-8393-0788
Ida ParamonovCNAG-CRG, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Solve-RD-DITF-ITHACA
Aurélien TrimouilleService de Génétique Médicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.ORCID 0000-0002-3457-5684
Tjitske KleefstraDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Alain Verloes *Département de Génétique, APHP Robert DEBRE University Hospital and INSERM U1141, Paris, France.ORCID 0000-0003-4819-0264
Lisenka E L M Vissers *Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0001-6470-5497
Radboud University Nijmegen · NLInserm · FRKarolinska Institutet · SECharles University · CZBambino Gesù Children's Hospital · ITUniversity Medical Center Groningen · NLUniversity of Helsinki · FIUniversity of Siena · ITInstituto de Salud Carlos III · ESCentre for Genomic Regulation · ESUniversité de Bordeaux · FRUniversity of Bonn · DEUniversity of Campania "Luigi Vanvitelli" · ITJackson Laboratory · USUniversité Paris Cité · FRUniversity of Cambridge · GBUniversity of Manchester · GBUniversity of Tübingen · DE

Funding

Medical Research Council G1000848Medical Research Council MR/N010035/1Medical Research Council MR/N025431/1Medical Research Council MR/N025431/2Medical Research Council MR/N027302/1Medical Research Council MR/V009346/1Wellcome Trust 109915/Z/15/Z
6 · The paper itself

Abstract

The genetic etiology of intellectual disability remains elusive in almost half of all affected individuals. Within the Solve-RD consortium, systematic re-analysis of whole exome sequencing (WES) data from unresolved cases with (syndromic) intellectual disability (n = 1,472 probands) was performed. This re-analysis included variant calling of mitochondrial DNA (mtDNA) variants, although mtDNA is not specifically targeted in WES. We identified a functionally relevant mtDNA variant in MT-TL1 (NC_012920.1:m.3291T > C; NC_012920.1:n.62T > C), at a heteroplasmy level of 22% in whole blood, in a 23-year-old male with severe intellectual disability, epilepsy, episodic headaches with emesis, spastic tetraparesis, brain abnormalities, and feeding difficulties. Targeted validation in blood and urine supported pathogenicity, with heteroplasmy levels of 23% and 58% in index, and 4% and 17% in mother, respectively. Interestingly, not all phenotypic features observed in the index have been previously linked to this MT-TL1 variant, suggesting either broadening of the m.3291T > C-associated phenotype, or presence of a co-occurring disorder. Hence, our case highlights the importance of underappreciated mtDNA variants identifiable from WES data, especially for cases with atypical mitochondrial phenotypes and their relatives in the maternal line.

Indexed as

EpilepsyExome SequencingHumansIntellectual DisabilityMaleMutationQuadriplegiaRNA, Transfer, LeuYoung AdultMT-TL1 tRNA, humanRNA, Transfer, Leu

Identifiers

PMID34075211
PMCPMC8440635
OpenAlexW3165718938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.